Home > Publications Database > Experience of Younger-Onset Dementia Stigma: Protocol for a Constructivist Grounded Theory Study Based on Qualitative Episodic Interviews With People Living With Dementia and Their Significant Others > print

001     268791
005     20240421003633.0
024 7 _ |a 10.1177/16094069241232346
|2 doi
024 7 _ |a altmetric:159824607
|2 altmetric
037 _ _ |a DZNE-2024-00334
082 _ _ |a 050
100 1 _ |a Berner, Nora
|0 P:(DE-2719)9002522
|b 0
|e First author
|u dzne
245 _ _ |a Experience of Younger-Onset Dementia Stigma: Protocol for a Constructivist Grounded Theory Study Based on Qualitative Episodic Interviews With People Living With Dementia and Their Significant Others
260 _ _ |a London
|c 2024
|b Sage Publishing
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1713170014_9660
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Stigma based on younger-onset dementia (YOD) is a significant challenge for individuals living with the condition and their significant others (i.e., family and/or friends) as well as for a society that aspires to be inclusive, ensure social participation, and enable all people to exercise their civil and human rights. The STELDA study aims to develop a theoretical framework of YOD stigma and stigmatization that is empirically grounded in the lived experience of people living with younger-onset dementia (PlwYOD) and their significant others and to identify ways of counteracting YOD stigmatization processes in the sociocultural context of Germany on a lifeworld level. The research question is as follows: How do PlwYOD and their adult significant others experience stigma and stigmatization based on YOD in their lifeworlds, and what implications do these experiences have for their actions in their lifeworlds? The study is designed as a constructivist grounded theory (CGT) study. Qualitative episodic interviews with community-dwelling PlwYOD and their adult significant others will be conducted to give participants the opportunity to share their individual narratives and express their subjective views. As an outcome, recommendations for action will be developed for the public and for professionals in diverse settings. On a methodological level, novel insights will be gained regarding specific issues related to qualitative research with PlwYOD and their significant others.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to DataCite
700 1 _ |a Hohmann, Andreas
|0 P:(DE-2719)9002235
|b 1
|u dzne
700 1 _ |a Yilmaz, Betuel
|0 P:(DE-2719)9002474
|b 2
|u dzne
700 1 _ |a Teupen, Sonja
|0 P:(DE-2719)2812481
|b 3
|e Last author
|u dzne
773 _ _ |a 10.1177/16094069241232346
|g Vol. 23, p. 16094069241232346
|0 PERI:(DE-600)2135788-2
|p 16094069241232346
|t International journal of qualitative methods
|v 23
|y 2024
|x 1609-4069
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/268791/files/DZNE-2024-00334.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/268791/files/DZNE-2024-00334.pdf?subformat=pdfa
909 C O |o oai:pub.dzne.de:268791
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)9002522
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)9002235
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 2
|6 P:(DE-2719)9002474
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 3
|6 P:(DE-2719)2812481
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2024
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-08-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-08-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0130
|2 StatID
|b Social Sciences Citation Index
|d 2023-08-22
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-08-22
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b INT J QUAL METH : 2022
|d 2023-08-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1180
|2 StatID
|b Current Contents - Social and Behavioral Sciences
|d 2023-08-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2023-01-29T12:52:09Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2023-01-29T12:52:09Z
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2023-08-22
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-08-22
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2023-08-22
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b INT J QUAL METH : 2022
|d 2023-08-22
915 _ _ |a National-Konsortium
|0 StatID:(DE-HGF)0430
|2 StatID
|d 2023-08-22
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-08-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-08-22
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Double anonymous peer review
|d 2023-01-29T12:52:09Z
920 1 _ |0 I:(DE-2719)5000076
|k AG Teupen
|l Methods in Health Care Research
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)5000076
980 1 _ |a FullTexts

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21